Connect with us

Health

Experimental women's cancer drug boosts survival rates in notable study

Published

on

Experimental women's cancer drug boosts survival rates in notable study

A new drug is showing promise in tackling treatment-resistant ovarian cancer.

Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve overall survival and progression of the disease when matched with a chemotherapy drug called nab-paclitaxel.

The ROSELLA trial, conducted in collaboration with The GOG Foundation, analyzed 381 patients around the world, including the U.S., Europe, South Korea, Brazil, Argentina, Canada and Australia, according to a press release.

AI DETECTS OVARIAN CANCER BETTER THAN HUMAN EXPERTS IN NEW STUDY

The large, randomized phase 3 study revealed a 30% reduction in risk of disease progression in patients with platinum-resistant ovarian cancer, compared to those just treated with nab-paclitaxel. (Some types of chemotherapy contain the element platinum.)

Advertisement

Patients whose disease returns less than six months after receiving platinum-containing therapy have “platinum-resistant” disease, according to Corcept Therapeutics. (iStock)

The researchers also noted “significant improvement” in overall survival with this combination of drugs.

Relacorilant, which is administered as an oral pill, was reportedly “well-tolerated” by patients without increased side effects.

“A 30% decrease in risk of recurrence and a 31% decreased risk of death is promising.”

The drug is administered by mouth one day before, the day of and one day after nab-paclitaxel therapy, which is given via infusion every week.

Advertisement

The findings will be presented at a medical conference later this year, researchers say. Results from the Phase 2 were published in the Journal of Clinical Oncology in 2023.

OVARIAN CANCER TREATMENT ON FAST TRACK FOR FDA APPROVAL AS CHEMO ALTERNATIVES EMERGE: ‘WE’RE MAKING PROGRESS’

Ovarian cancer is the fifth most common cause of cancer death in women and is the deadliest of gynecologic cancers, according to the Ovarian Cancer Research Alliance.

Alexander B. Olawaiye, MD, director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh and principal investigator in the ROSELLA trial, discussed the results with Fox News Digital.

Relacorilant, which is administered as an oral pill, was reportedly “well-tolerated” by patients without increased side effects. (iStock)

Advertisement

Olawaiye echoed that this new agent is the “first of its kind” in the battle against cancers that don’t have many treatment options.

“That’s what makes the findings of this study really exciting, because it did show a very significant improvement in both progression-free survival and overall survival,” he said.

OVARIAN CANCER SIGNS, SYMPTOMS, DIAGNOSIS AND TREATMENT OPTIONS

The expert shared his gratitude to his research team, mentioning that they “never stopped trying” for women undergoing treatment.

“I want to congratulate the women that are being treated for ovarian cancer — first, for helping us to do this trial and second, for the potential that we may now have another option on the block.”

Advertisement

Patients in the trial showed a 30% decrease in death risk, according to researchers. (iStock)

Dr. Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida, also commented on these findings in an interview with Fox News Digital.

“We know ovarian cancer is very, very difficult to treat, particularly in those patients who have a disease that’s resistant to the standard chemotherapies,” he said.

“For a long time, we’ve been trying to find treatments that can help patients not only keep the disease away longer, but also live longer. And most of the trials, unfortunately, have been negative.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

Slomovitz, a member of The GOG Foundation, said he considers the ROSELLA trial an “opportunity to use a unique drug” that has shown “positive, encouraging results.”

“A 30% decrease in risk of recurrence and a 31% decreased risk of death is promising,” he stated.

Relacorilant is administered one day before, the day of and one day after nab-paclitaxel chemotherapy, which is given via infusion every week. (iStock)

“To see data like this is refreshing, and it represents something that’s exciting for our patients who suffer from ovarian cancer.”

Olawaiye shared his hope for the treatment to receive clinical approval “pretty soon.”

Advertisement

For more Health articles, visit www.foxnews.com/health

As research and technology advance, various cancer treatments have surfaced in the last several years.

      

Olawaiye commented that the past two decades have been a “very exciting time,” as there’s been an “explosion of approvals” for cancer therapies.

“Today’s news about Relacorilant is just another addition,” he said.

Advertisement

Health

Matt Damon’s Gluten-Free Diet Helped Him Lose 18 Pounds

Published

on

Matt Damon’s Gluten-Free Diet Helped Him Lose 18 Pounds


Advertisement


Matt Damon’s Weight Loss: Actor Drops 18 Lbs with This Diet | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Deadly cancer risk could drop with single 10-minute workout, study suggests

Published

on

Deadly cancer risk could drop with single 10-minute workout, study suggests

NEWYou can now listen to Fox News articles!

A single 10-minute workout may trigger blood changes that help fight colon cancer.

That’s according to new research from scientists at Newcastle University, who found that exercise quickly changes the blood in ways that affect colon cancer cells in the lab.

In the study, the U.K. researchers exposed colon cancer cells to human blood serum collected immediately after exercise, finding that the cells repaired DNA damage faster and showed gene activity patterns linked to slower growth.

SPIKE IN DEADLY CANCER BEFORE 50 LINKED TO COMMON CONVENIENCE FOODS

Advertisement

The blood samples came from 30 adults who had just completed a short, high-intensity cycling workout that lasted about 10 to 12 minutes, according to a press release.

Even a 10-minute burst of intense exercise may send protective signals through the blood that affect colon cancer cells, researchers say. (iStock)

Samuel T. Orange, an associate professor at Newcastle University and one of the study’s authors, spoke with Fox News Digital about the findings.

“Our findings show that exercise rapidly triggers molecular changes in the bloodstream that can act directly on colon cancer cells, reshaping gene activity and supporting DNA damage repair,” he said.

COMMON OVER-THE-COUNTER MEDICATION SLASHES COLORECTAL CANCER RECURRENCE IN HALF

Advertisement

The results suggest that even brief activity can make a difference. “Every movement matters. Exercise doesn’t need to last hours or happen in a gym,” Orange added.

The research suggests that exercise quickly triggers changes in the blood that affect colon cancer cells and helps support DNA repair. (iStock)

One of the most surprising findings, according to the researcher, was how strong the biological response was after even a single workout.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Exercise altered the activity of more than 1,000 genes in colon cancer cells,” he shared.

Advertisement

Even brief bouts of activity can make a difference, the researcher said.  (iStock)

The study findings suggest that the effect is driven by exercise-triggered molecules released into the bloodstream, sometimes referred to as “exerkines,” which act like chemical messengers and send signals throughout the body.

“Each time you exercise, you trigger biological signals that support health and resilience to diseases such as cancer, diabetes and heart disease,” Orange said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The researchers cautioned that the study was conducted using cancer cells grown in the laboratory, not in patients.

Advertisement

The findings are based on experiments using colon cancer cells grown in the lab, not studies conducted in people, the researchers noted. (iStock)

The study involved 30 healthy male and female volunteers between the ages of 50 and 78. Their blood samples were used to carry exercise-triggered signals to cancer cells grown in the lab.

CLICK HERE FOR MORE HEALTH STORIES

“These findings now need to be replicated in people with cancer,” Orange said. “We also need to better understand the longer-term effects of repeated exercise signals over time.”

Despite the limitations, the researcher said the findings strengthen the case for exercise as an important part of colon cancer prevention.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Each time you move your body and get a little breathless, you’re contributing to better health and may help influence biological processes linked to bowel cancer,” he added.

Advertisement
Continue Reading

Health

Brain Health Challenge: Try a Brain Teaser

Published

on

Brain Health Challenge: Try a Brain Teaser

Welcome back! For Day 4 of the challenge, let’s do a short and fun activity based around a concept called cognitive reserve.

Decades of research show that people who have more years of education, more cognitively demanding jobs or more mentally stimulating hobbies all tend to have a reduced risk of cognitive impairment as they get older.

Advertisement

Experts think this is partly thanks to cognitive reserve: Basically, the more brain power you’ve built up over the years, the more you can stand to lose before you experience impairment. Researchers still don’t agree on how to measure cognitive reserve, but one theory is that better connections between different brain regions corresponds with more cognitive reserve.

To build up these connections, you need to stimulate your brain, said Dr. Joel Salinas, a neurologist at NYU Langone Health and the founder and chief medical officer of the telehealth platform Isaac Health. To do that, try an activity that is “challenging enough that it requires some effort but not so challenging that you don’t want to do it anymore,” he said.

Advertisement

Speaking a second language has been shown to be good for cognition, as has playing a musical instrument, visiting a museum and doing handicrafts like knitting or quilting. Reading is considered a mentally stimulating hobby, and experts say you’ll get an even bigger benefit if you join a book club to make it social. Listen to a podcast to learn something new, or, better yet, attend a lecture in person at a local college or community center, said Dr. Zaldy Tan, the director of the Memory and Healthy Aging Program at Cedars-Sinai. That adds a social component, plus the extra challenge of having to navigate your way there, he said.

A few studies have found that playing board games like chess can be good for your brain; the same goes for doing crossword puzzles. It’s possible that other types of puzzles, like those you find in brain teaser books or from New York Times Games, can also offer a cognitive benefit.

But there’s a catch: To get the best brain workout, the activity should not only be challenging but also new. If you do “Wordle every day, it’s like well, then you’re very, very good at Wordle, and the Wordle part of your brain has grown to be fantastic,” said Dr. Linda Selwa, a clinical professor of neurology at the University of Michigan Medical School. “But the rest of your mind might still need work.”

Advertisement

So play a game you’re not used to playing, Dr. Selwa said. “The novelty seems to be what’s driving brain remodeling and growth.”

Today, we want you to push yourself out of your cognitive comfort zone. Check out an online lecture or visit a museum with your challenge partner. Or try your hand at a new game, below. Share what novel thing you did today in the comments, and I’ll see you tomorrow for Day 5.

Advertisement
Continue Reading

Trending